The Ethics of Prescription of Placebos to Patients with Major Depressive Disorder

The Ethics of Prescription of Placebos to Patients with Major Depressive Disorder

Bibliographic Details
Main Authors:	Shun-Jie Chua, Mark Pitts
Format:	Article
Language:	English
Published:	Wolters Kluwer 2015-01-01
Series:	Chinese Medical Journal
Online Access:	http://www.cmj.org/article.asp?issn=0366-6999;year=2015;volume=128;issue=11;spage=1555;epage=1557;aulast=Chua

Similar Items

The sunhine induced placebo effect in Major Depressive Disorder patients exhibits gender differences
by: J. Gailledreau, et al.
Published: (2023-03-01)

Esketamine versus placebo on time to remission in major depressive disorder with acute suicidality
by: Dong-Jing Fu, et al.
Published: (2023-08-01)

Efficacy of Botox versus Placebo for Treatment of Patients with Major Depression
by: Abbas ZAMANIAN, et al.
Published: (2017-06-01)

Pharmacometabolomics of response to sertraline and to placebo in major depressive disorder - possible role for methoxyindole pathway.
by: Hongjie Zhu, et al.
Published: (2013-01-01)

Artificial intelligence approach for the analysis of placebo-controlled clinical trials in major depressive disorders accounting for individual propensity to respond to placebo
by: Roberto Gomeni, et al.
Published: (2023-04-01)

Are child and adolescent responses to placebo higher in major depression than in anxiety disorders? A systematic review of placebo-controlled trials.
by: David Cohen, et al.
Published: (2008-07-01)

Is placebo useful in the treatment of major depression in clinical practice?
by: Marchesi C, et al.
Published: (2013-06-01)

Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: post hoc analyses of three placebo-controlled studies
by: Thase ME, et al.
Published: (2018-12-01)

Cerebral Blood Perfusion Predicts Response to Sertraline versus Placebo for Major Depressive Disorder in the EMBARC Trial
by: Crystal M. Cooper, et al.
Published: (2019-04-01)

Stressful life events preceding the onset of depression in Asian patients with major depressive disorder
by: Park, S., et al.
Published: (2015)

Major Depressive Disorder
by: G Grobler
Published: (2013-08-01)

Comparison of brexpiprazole, aripiprazole, and placebo for Japanese major depressive disorder: A systematic review and network meta‐analysis
by: Taro Kishi, et al.
Published: (2024-03-01)

Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placebo
by: Fu, CHY, et al.
Published: (2024)

Functioning outcomes with adjunctive treatments for major depressive disorder: a systematic review of randomized placebo-controlled studies
by: Weiller E, et al.
Published: (2017-12-01)

Suicide‐specific mortality among patients with treatment‐resistant major depressive disorder, major depressive disorder with prior suicidal ideation or suicide attempts, or major depressive disorder alone
by: David M. Kern, et al.
Published: (2023-08-01)

Roles of Trait Mindfulness in Behavioral Activation Mechanism for Patients With Major Depressive Disorder
by: Koki Takagaki, et al.
Published: (2020-04-01)

Psychiatric comorbidities in patients with major depressive disorder
by: Thaipisuttikul P, et al.
Published: (2014-11-01)

Patients’ acceptance of placebo antibiotics in Japan: a prescription for antimicrobial resistance
by: Atsushi Ito, et al.
Published: (2022-12-01)

Resilience and Attachment in Patients with Major Depressive Disorder and Bipolar Disorder
by: Ambra Craba, et al.
Published: (2023-06-01)

Efficacy and Safety of Antidiabetic Agents for Major Depressive Disorder and Bipolar Depression: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials
by: Jian Zhang, et al.
Published: (2024-02-01)

Efficacy of Gemfibrozil as an Adjunct to Sertraline in Major Depressive Disorder, A Double-Blind, Randomized, and Placebo-Controlled Clinical Trial
by: Atefeh Zandifar, et al.
Published: (2021-01-01)

Commentary: Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression.
by: Eiko I Fried, et al.
Published: (2015-08-01)

Perfectionism in Major Depressive Disorder
by: Gülen Say
Published: (2020-12-01)

SUMOylation and Major Depressive Disorder
by: Seok-Won Jeoung, et al.
Published: (2022-07-01)

GENETICS OF MAJOR DEPRESSIVE DISORDER
by: Pomohaibo V. M., et al.
Published: (2019-04-01)

Temperament and major depressive disorder
by: Mneimneh Zeina, et al.
Published: (2010-04-01)

Lipidomics in Major Depressive Disorder
by: Andreas Walther, et al.
Published: (2018-10-01)

Major depressive disorder in chronic heart failure patients: Does silent cerebral infarction cause major depressive disorder in this patient population?
by: Güliz Kozdağ, et al.
Published: (2015-09-01)

Association between depression severity and fitness in in-patients with major depressive disorders
by: Jan-Niklas Kreppke, et al.
Published: (2023-02-01)

Comparison of Citalopram and Metacognitive Therapy on Depression in Patients with Major Depressive Disorder
by: Gholam Reza Kheirabadi, et al.
Published: (2017-11-01)

Effects of Celecoxib on Electroconvulsive Therapy-Induced Cognitive Impairment in Patients With Major Depressive Disorder: A Pilot, Double-Blind, Placebo-Controlled Trial
by: Nafiseh Banaha, et al.
Published: (2020-05-01)

The efficacy and safety of Anyu Peibo Capsule in the treatment of patients with major depressive disorder in China: study protocol for a randomized placebo-controlled trial
by: Jingjing Huang, et al.
Published: (2021-09-01)

Tricyclic antidepressants versus ‘active placebo’, placebo or no intervention for adults with major depressive disorder: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis
by: Caroline Kamp Jørgensen, et al.
Published: (2021-08-01)

Attenuated Visual Function in Patients with Major Depressive Disorder
by: Kyoung In Jung, et al.
Published: (2020-06-01)

Olfactory brain activations in patients with Major Depressive Disorder
by: Theresa Herrmann, et al.
Published: (2023-06-01)

Characteristics of implicit schemas in patients with major depressive disorder
by: Yuan Wang, et al.
Published: (2022-06-01)

Electrophysiological correlates of mindfulness in patients with major depressive disorder
by: Jan Sarlon, et al.
Published: (2022-10-01)

Effect of Ketamine in the Treatment of Patients with Major Depressive Disorder
by: F Kheirkhah, et al.
Published: (2010-10-01)

Emotional working memory in patients with major depressive disorder
by: Mi Li, et al.
Published: (2018-05-01)

The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder
by: Bing Cao, et al.
Published: (2019-01-01)